This test is most useful if any of these apply to you.
If you live in a region where paper mulberry trees grow heavily, your spring allergies may not be coming from the usual suspects. Paper mulberry pollen is one of the dominant airborne pollens in places like Southwest China and Islamabad, where it has been linked to allergic rhinitis and asthma exacerbations during peak season.
This test checks whether your immune system has produced antibodies specifically against paper mulberry pollen. A positive result tells you the tree is a likely contributor to your symptoms, which can shape decisions about avoidance, medication timing, and whether allergen-specific immunotherapy might be worth considering.
The test measures IgE (immunoglobulin E) in your blood that specifically binds to proteins from paper mulberry (Broussonetia papyrifera) pollen. IgE is a type of antibody your immune system makes after it has decided a harmless substance is a threat. When that antibody coats immune cells called mast cells and basophils, the next encounter with the pollen triggers them to release histamine and other chemicals, producing the runny nose, itchy eyes, congestion, and wheezing of an allergic reaction.
A positive result means your immune system is sensitized to paper mulberry. Sensitization is not the same as a clinical allergy. Many people have detectable IgE to allergens without ever developing symptoms. In a study of 1,000 healthy Japanese adults, 78% had IgE to at least one inhaled allergen, and in a study of 501 Austrian adolescents, more than half had IgE to at least one molecule. The test result becomes most meaningful when it matches a real-world pattern of symptoms during paper mulberry pollen season.
Paper mulberry is not just background pollen. In Southwest China, it accounted for 58.6% of total pollen grains measured throughout the year and has been identified as a significant cause of allergic rhinitis. In Islamabad, where the tree was planted heavily decades ago, an observational study of 324 people found that high paper mulberry pollen concentrations were associated with asthma exacerbations during peak season.
If you have unexplained respiratory symptoms in late winter or early spring and you live in or have traveled through a paper mulberry-heavy region, this test can help connect the dots. Standard allergy panels often focus on grasses, birch, ragweed, and dust mites, so paper mulberry sensitization can be missed unless someone specifically looks for it.
The strongest clinical link for paper mulberry pollen is with seasonal allergic rhinitis (hay fever) and asthma flares. In the Islamabad study, asthma exacerbations rose with high pollen counts, suggesting that for sensitized people, the tree can push borderline-controlled asthma into clinical trouble.
This pattern mirrors what is known about allergen-specific IgE more broadly. Across population studies, higher specific IgE to pollens is consistently associated with allergic rhinitis severity, asthma symptoms, and poorer quality of life. In a study of 1,476 school-aged children in Japan, high specific IgE to local pollen was linked to moderate-to-severe rhinitis symptoms and worse quality-of-life scores. A separate cohort of 8,629 people with allergic rhinitis found that higher specific IgE corresponded to more severe symptoms, while levels naturally decline with age, easing symptoms in older adults.
Paper mulberry pollen can also trip up your immune system through cross-reactivity, where antibodies built against one allergen react to similar-looking proteins in another. A case report describing systemic allergic reactions to mulberry fruit found that the patient's blood contained IgE that bound a roughly 17 kilodalton protein band (a measure of protein size), suggested to belong to a family called PR-10 proteins. PR-10 proteins are also found in birch pollen, hazelnut, apple, and many other plants, and are a common source of cross-reactive allergy.
What this means for you: if you test positive for paper mulberry IgE but also react to birch or to certain raw fruits, the pattern may reflect a shared protein family rather than independent allergies. A specialist can help untangle which exposure is the real driver of your symptoms.
This distinction matters enough to call out separately. A positive paper mulberry IgE result tells you that your immune system has built antibodies against the pollen. It does not by itself tell you that you will react when exposed. Across multiple population studies, large fractions of healthy adults have positive specific IgE results without symptoms.
Conversely, a negative or low result does not fully rule allergy out. Some people with clear allergic symptoms have normal total IgE or undetectable specific IgE. The test is most useful when combined with your symptom history and, when needed, skin prick testing or a specialist's clinical assessment.
A single IgE value is a snapshot, not a fixed trait. Levels of specific IgE shift with ongoing exposure, age, and treatment. Allergen-specific IgE generally declines with age, which is why older adults often report milder seasonal symptoms than they had in their thirties. If you start allergen-specific immunotherapy, your treating clinician will typically watch specific IgE alongside other markers; immunotherapy can lower allergen-specific IgE over months while raising blocking IgG4 antibodies that calm the allergic response.
A reasonable approach for someone managing seasonal symptoms is to get a baseline test, retest in 6 to 12 months if you start immunotherapy or change exposure significantly (for example, by moving regions), and then check every 1 to 2 years to track trajectory. The trend over time is more informative than any single number, especially for an emerging marker without standardized clinical cutoffs.
A few factors can blur the interpretation of a single reading. Knowing them helps you decide whether your result truly reflects your immune state.
If your paper mulberry IgE comes back positive and your symptoms fit a seasonal pattern, the next steps are clinical, not numerical. A consultation with an allergist can confirm whether the result matches your symptom timeline, rule out cross-reactivity with birch or other tree pollens using component-resolved testing, and discuss whether avoidance, pre-season antihistamines or nasal steroids, or allergen-specific immunotherapy makes sense for you.
If the result is positive but you have no symptoms, no immediate action is needed. Treat it as useful background information: you have a sensitization that could become clinically relevant if your exposure increases, for example through a move or a change in local plantings. If the result is negative but your symptoms strongly suggest pollen allergy, a broader panel of tree, grass, and weed allergens, plus skin prick testing, can help find the real trigger.
Evidence-backed interventions that affect your Paper Mulberry IgE level
Paper Mulberry IgE is best interpreted alongside these tests.